Penetration of beta-lactams through Pseudomonas aeruginosa porin channels.
Godfrey, A J
Diminished permeation of beta-lactam antibiotics in a mutant (PCC23) of Pseudomonas aeruginosa, PAO503, was investigated. Resistance to beta-lactam antibiotics could not be correlated to a change in the beta-lactamase or target proteins in strain PCC23 but was correlated with decreased permeability. In liposome swelling assays, the permeability defect was associated with strain PCC23 porin. Amino acid analysis did not show significant difference of the porin of the mutant (PCC23) from that of the parent (PAO503). Changes in the behavior of isolated porin from PCC23 in migration in sodium dodecyl sulfate-polyacrylamide gels and in response to trypsin digestion as well as preferential labeling of PCC23 by a monoclonal antibody with a preference for the modified form of porin F (F) indicate that a structural alteration had occurred in this strain and correlated with the change in permeability.
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=174906
- Porin channels in Escherichia coli: studies with beta-lactams in intact cells.
- Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa.
- Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate.
- In vitro studies of investigational beta-lactams as possible therapy for Pseudomonas aeruginosa endocarditis.
- In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.